Plan B Expected To Take Center Stage During Von Eschenbach Confirmation
This article was originally published in The Tan Sheet
Executive Summary
FDA's handling of Barr Lab's switch application for Plan B emergency contraception likely will be a focal point in the debate surrounding Senate confirmation of Andrew von Eschenbach, MD, as FDA commissioner